Mark J Foley Glaukos Corp (GKOS) insider trading activity

Mark J Foley is of GLAUKOS Corp. Currently has a direct ownership of 58,389 shares of GKOS, which is worth approximately $5.26 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 1,168 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.4K

2.04% 3M change

63.1% 12M change

Total Value Held $5.26 Million

Mark J Foley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	-	1,168 Added 1.96%	58,389 Common Stock
May 29 2025	BUY Grant, award, or other acquisition	-	2,108 Added 3.55%	57,221 Common Stock
Feb 26 2025	SELL Open market or private sale	$2,497,334 $120.72 p/Share	20,687 Reduced 27.61%	54,249 Common Stock
Feb 26 2025	BUY Exercise of conversion of derivative security	$1,134,000 $28.35 p/Share	40,000 Added 34.8%	74,936 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	864 Added 2.36%	35,800 Common Stock
May 30 2024	BUY Grant, award, or other acquisition	-	1,716 Added 4.68%	34,936 Common Stock
Feb 23 2024	SELL Open market or private sale	$423,487 $92.87 p/Share	4,560 Reduced 12.07%	33,220 Common Stock

Feb 23 2024	BUY Exercise of conversion of derivative security	$72,800 $7.28 p/Share	10,000 Added 20.93%	37,780 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	3,230 Added 10.42%	27,780 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	2,948 Added 10.72%	24,550 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	4,364 Added 16.81%	21,602 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	2,486 Added 12.6%	17,238 Common Stock
Jun 03 2021	BUY Grant, award, or other acquisition	-	2,382 Added 13.9%	14,752 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	1,184 Added 8.74%	12,370 Common Stock

Also insider at

RVNC

Revance Therapeutics, Inc. Healthcare

President & CEO

MJF

Mark J Foley

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GKOS shares.

Notify only if

Value

Insider Trading

Get notified when an Glaukos Corp insider buys or sells GKOS shares.

Notify only if

Operation

Value

Type

News

Receive news related to GLAUKOS Corp

Track Activities on GKOS

Account